N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study
about
Pharmacotherapies for cannabis dependenceState of the art treatments for cannabis dependenceN-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of actionSimilarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivityProgress toward pharmacotherapies for cannabis-use disorder: an evidence-based reviewRapid, transient synaptic plasticity in addictionGlutamate Transporter GLT-1 as a Therapeutic Target for Substance Use DisordersEfficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an updatePotential role of N-acetylcysteine in the management of substance use disordersPharmacological treatments in pathological gambling.Pharmacological means of reducing human drug dependence: a selective and narrative review of the clinical literature.Cognitive enhancers in the treatment of substance use disorders: clinical evidence.New Developments in Understanding and Treating Adolescent Marijuana DependenceN-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic reviewN-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects.A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependenceMolecular strategies for targeting antioxidants to mitochondria: therapeutic implications.Pharmacological treatment of cannabis dependence.Cannabis and psychopathology: The meandering journey of the last decadeN-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance spectroscopy study.A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents.The effects of N-Acetylcysteine on frontostriatal resting-state functional connectivity, withdrawal symptoms and smoking abstinence: A double-blind, placebo-controlled fMRI pilot study.Treatment of Cannabis Use Disorder: Current Science and Future Outlook.Screening Medications for the Treatment of Cannabis Use Disorder.Evidence-based Treatment Options in Cannabis Dependency.Glutamatergic medications for the treatment of drug and behavioral addictions.Systematic review of N-acetylcysteine in the treatment of addictions.Glutamate Transport: A New Bench to Bedside Mechanism for Treating Drug AbuseCorticostriatal circuitry in regulating diseases characterized by intrusive thinking.The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use DisordersSimilarities and Differences in Neurobiology.N-acetylcysteine in the treatment of craving in substance use disorders: Systematic review and meta-analysis.Effects of L-cysteine on reinstatement of ethanol-seeking behavior and on reinstatement-elicited extracellular signal-regulated kinase phosphorylation in the rat nucleus accumbens shell.Treatment of cannabis dependence using escitalopram in combination with cognitive-behavior therapy: a double-blind placebo-controlled study.The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal.A potential role for N-acetylcysteine in the management of methamphetamine dependence.The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial.The Winding Road to Relapse: Forging a New Understanding of Cue-Induced Reinstatement Models and Their Associated Neural Mechanisms.Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation.Psychosocial and pharmacological interventions for the treatment of cannabis use disorder.
P2860
Q24187250-81D3CCC7-5072-4CF8-94C9-B2EFE4247524Q24607810-6E8FCEE6-C63C-4648-99A0-187AF62CF206Q24615952-77408E98-A352-4D31-8EAB-EA5D97FF4E49Q24616099-0DDA077F-0FD4-45B2-97D0-7BBC31E97207Q26746192-8FB90652-D860-41C9-8537-E0FC108CB2C2Q26999059-8EC8D0B6-4F16-4008-940E-A7747D1A38E5Q28081726-1573ECDC-FE72-451C-89EB-C15F9F65DDF7Q28299995-69888D11-E489-4869-BF48-4CA89BFDAF27Q28306130-4EF9FCC7-B147-4BF1-AF7B-C245B63985CFQ33582039-B098ADDB-2406-4F0D-8D18-A2794D67CEE9Q33582063-01543508-F24F-4F08-835D-14D9256E59DFQ34183988-17A0A8BB-B239-4C63-A291-ADC32A516D69Q34288989-94EDB3AF-6C0D-4B5C-9BA2-466F903DE39CQ34473631-87BDFB1A-087A-4807-A99A-C8ED9107E9EEQ34543171-45325AD8-A2A8-47FD-81D7-93FA92746A93Q35144056-86A935B4-C792-48BB-BDB5-D9BA45633AC6Q35148462-B433C876-D47B-4240-BA50-808E9AA88514Q35210350-368D9F6A-B2F6-4B2E-90EE-42F504843289Q35716762-32E789AB-6108-4112-96B6-298D301A75A5Q36100301-C5A45E04-4B14-46FB-9557-FD95B7C65B19Q36137192-11A1E521-9EC5-4D4A-B5C2-9012345DB930Q36248846-4B310963-C954-4A45-B193-121C6BF46C39Q36936298-5C73607E-B99F-44FB-82F7-29B5743E7BF7Q37187618-B21DB504-59FA-41E6-B885-0EE5381D7261Q37396986-721B8FFE-BA93-4471-9F24-40DADB8F42EFQ37871133-FCD44DA0-1FE3-4944-B6A1-1EACCC1E9B1CQ38199954-06A8F839-90E3-4C64-9C96-6E581795729AQ38729846-E15C71DB-0185-4E9E-9F45-45759E09A411Q38805967-5DC14788-AD30-4669-9FFC-81195E1CD633Q38950639-19FD7544-D7B2-4A92-AE85-E289382AAA2CQ43075618-D59BD47D-B90E-408A-9C2E-C6E157C4F7A7Q43076061-3D351A0C-BF5B-4E58-9AF1-358AFF27D8FFQ43519503-FA9B85E2-BF4D-432E-AC03-5DB3A7A68139Q47817946-E9D45345-2EC9-4233-B0F2-3911FB460947Q47963315-1B801DC8-48BB-493D-8243-DE240E893405Q48013273-CC989008-878D-4BCF-BD4A-A7C69689E84DQ50138551-4174A3A9-55A6-4F12-B069-168B165CE76DQ50248388-DE05ABCE-A475-4187-9474-BA28FADDA3B6Q52310360-5DBE8990-18B6-48C7-A362-FBEB54911DD4Q52316000-25CE7E5A-B654-49DC-AA6E-575F2172078D
P2860
N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study
@ast
N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study
@en
type
label
N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study
@ast
N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study
@en
prefLabel
N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study
@ast
N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study
@en
P2093
P2860
P1476
N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study
@en
P2093
Kevin M Gray
Matthew J Carpenter
Noreen L Watson
Steven D Larowe
P2860
P304
P356
10.1111/J.1521-0391.2009.00027.X
P577
2010-03-01T00:00:00Z